Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors and Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00089271
What this trial is testing

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+47 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01971476
What this trial is testing

Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known

Who this might be right for
LeukemiaNeoplasms
Boehringer Ingelheim 22
Early research (Phase 1)UnknownNCT05226468
What this trial is testing

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

Who this might be right for
Advanced Solid TumorRelapsed AMLRefractory AML
New Epsilon Innovation Limited 24
Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)Study completedNCT00016172
What this trial is testing

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT05302037
What this trial is testing

Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)

Who this might be right for
CancerMalignancyRefractory Cancer+1 more
CytoMed Therapeutics Pte Ltd 12
Testing effectiveness (Phase 2)UnknownNCT05028478
What this trial is testing

CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorHematologic Malignancies
Curon Biopharmaceutical (Australia) Co Pty Ltd 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852
What this trial is testing

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Ended earlyNCT02440685
What this trial is testing

Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Follicular+18 more
Asana BioSciences 51
Testing effectiveness (Phase 2)UnknownNCT06433830
What this trial is testing

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Who this might be right for
ThrombocytopeniaRadiotherapy Side Effect
Sir Run Run Shaw Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Early research (Phase 1)Looking for participantsNCT07036133
What this trial is testing

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

Who this might be right for
Advanced Solid TumorsHematologic Malignancies
Acrotech Biopharma Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00725634
What this trial is testing

Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

Who this might be right for
Malignant Solid TumorLymphomasMultiple Myeloma
AVEO Pharmaceuticals, Inc. 41
Testing effectiveness (Phase 2)WithdrawnNCT06400264
What this trial is testing

Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02143635
What this trial is testing

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Who this might be right for
Advanced Solid and Hematological TP53wt Tumors
Novartis Pharmaceuticals 208
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Early research (Phase 1)Study completedNCT00996957
What this trial is testing

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Advanced Solid TumorsMultiple Myeloma
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 37
Next Page